3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 24 0 1 0 0 0 0 0999 V2000
0.6069 -1.8927 0.9893 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1746 -1.6879 -1.2394 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7945 0.8001 -0.9546 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2369 0.1793 0.2512 C 0 0 2 0 0 0 0 0 0 0 0 0
-1.3924 0.1572 1.2577 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6248 0.5787 0.4626 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2103 0.4490 -0.9886 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9667 0.9684 0.7527 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1939 -1.2182 -0.1115 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0331 1.0549 -0.2947 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2836 0.6113 -0.1247 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2416 0.8514 2.0925 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.5647 -0.8370 1.6855 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.4993 -0.0344 0.7009 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.8717 1.6221 0.6946 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.3540 -0.5770 -1.3458 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.7767 1.1227 -1.6376 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.3186 0.4968 -1.8022 H 0 0 0 0 0 0 0 0 0 0 0 0
1.3638 0.5231 1.6741 H 0 0 0 0 0 0 0 0 0 0 0 0
0.6661 1.9920 1.0135 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7952 1.5491 -1.2331 H 0 0 0 0 0 0 0 0 0 0 0 0
0.8917 -2.8063 0.7737 H 0 0 0 0 0 0 0 0 0 0 0 0
4.0186 0.7241 -0.9141 H 0 0 0 0 0 0 0 0 0 0 0 0
3.5949 0.1295 0.7956 H 0 0 0 0 0 0 0 0 0 0 0 0
1 9 1 0 0 0 0
1 22 1 0 0 0 0
2 9 2 0 0 0 0
3 4 1 0 0 0 0
3 7 1 0 0 0 0
3 18 1 0 0 0 0
4 5 1 0 0 0 0
4 8 1 0 0 0 0
4 9 1 0 0 0 0
5 6 1 0 0 0 0
5 12 1 0 0 0 0
5 13 1 0 0 0 0
6 7 1 0 0 0 0
6 14 1 0 0 0 0
6 15 1 0 0 0 0
7 16 1 0 0 0 0
7 17 1 0 0 0 0
8 10 1 0 0 0 0
8 19 1 0 0 0 0
8 20 1 0 0 0 0
10 11 2 0 0 0 0
10 21 1 0 0 0 0
11 23 1 0 0 0 0
11 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(2R)-2-prop-2-enylpyrrolidine-2-carboxylic acid
4.2 InChl
InChI=1S/C8H13NO2/c1-2-4-8(7(10)11)5-3-6-9-8/h2,9H,1,3-6H2,(H,10,11)/t8-/m0/s1
4.3 InChlKey
WRBBRKMXTLLAOB-QMMMGPOBSA-N
4.4 Canonical SMILES
C=CCC1(CCCN1)C(=O)O
4.5 lsomeric SMILES
C=CC[C@]1(CCCN1)C(=O)O
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病